Activated neurotensin molecules and the uses thereof
US9821072B2 · kind B2 · utility
0Cited by
3References
7Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jan 19, 2015 |
| Grant date | Nov 21, 2017 |
| Priority date | — |
| Expiry date | Jan 19, 2035 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to activated neurotensin, pharmaceutical compositions comprising the same, and the uses thereof. The compounds and compositions of the invention may be used, e.g., to reduce body temperature, attenuate or halt seizures, reduce excitotoxicity, promote neuroprotection, reduce neuroinflammation and aberrant axonal sprouting or reduce pain.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.